THE IMPACT OF TREATMENT ON THE NATURAL-HISTORY OF ENDOMETRIOSIS

被引:62
作者
MAHMOOD, TA
TEMPLETON, A
机构
[1] Department of Obstetrics and Gynaecology, Aberdeen Maternity Hospital, Aberdeen AB9 2ZD, Cornhill Road
关键词
ENDOMETRIOSIS; NATURAL HISTORY; TREATMENT;
D O I
10.1093/oxfordjournals.humrep.a137229
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
A group of 50 infertile female patients were assessed laparoscopically to study the natural history of endometriosis. They were treated either with danazol (n = 21), or diathermy ablation (n = 13) or had conservative surgery with postoperative (n = 5) or were left untreated (n = 11). All these patients had second look laparoscopy performed after a mean interval of 12 months (range 9-18 months). Improvement was noted among 53% of those treated with danazol, 70% treated with diathermy, 80% treated with surgery and danazol and 27% of those left untreated. The status of endometriosis remained unchanged among 14% of those treated with danazol, 8% treated by diathermy and 9% of those left untreated. However, the disease became worse in the remaining women, 33% in the danazol treated group, 22% treated by diathermy, 20% treated with surgery and danazol and 64% of those left untreated. Thus treatment hinders progression in a majority of patients, and conversely, there is a small but definite spontaneous regression rate.
引用
收藏
页码:965 / 970
页数:6
相关论文
共 43 条
  • [11] Dmowski W.P., Radwanska E., Bkmor Z., Tummon I., Pepping P., Ovarian suppression induced with Buserelin or danazol in the management of endometriosis: A randomized comparative study, Fertil. Steril, 51, pp. 395-400, (1989)
  • [12] Evers J.L.H., The second look laparoscopy for evaluation of the result of medical treatment of endometriosis should not be performed during ovarian suppression, Fertil. Steril, 47, pp. 502-504, (1987)
  • [13] Fedele L., Bianchi S., Arcaini L., Vercellini P., Candiani G.B., GnRH agonists in the treatment of endometriosis, Acta Europ. Fertil, 19, pp. 5-12, (1988)
  • [14] Fedele L., Vercellini P., Viezzoli T., Marchini M., Candiani G.B., Second look laparoscopy in the treatment of endometriosis, Int. J. Fertil, 33, pp. 237-240, (1988)
  • [15] Franssen A.M.H., Kauer F.M., Chanda D.R., Ziylstra J.A., Rolland R., Endometriosis: Treatment with gonadotrophinreleasing hormone agonist Buserelin, Fertil. Steril, 51, pp. 401-408, (1989)
  • [16] Garcia C.R., David S.S., Pelvic endometriosis: Infertility and pelvic pain, Am. J. Obstet. Gynecol, 129, pp. 704-747, (1977)
  • [17] Gleicher N., El-Roeiy A., Confino E., Frieberg J., Is endometriosis an autoimmune disease?, Obstet. Gynecol, 70, pp. 115-122, (1987)
  • [18] Henig I., Rawlins R.G., Weinrib H.P., Dmowski W.P., Effects of danazol, gonadotrophin-releasing hormone agonist and cstrogen/progestogen combination on experimental endometriosis in the ovariectomized rat, Fertil. Steril, 49, pp. 349-355, (1988)
  • [19] Henzl M.R., Gonadotrophin-releasing hormone (GnRH) agonists in the management of endometriosis: A review, Clin. Obstet. GynecoL, 31, pp. 840-856, (1988)
  • [20] Janne O., Kauppila A., Kokko E., Lantto T., Ronnberg L., Vihko R., Estrogen and progestin receptors in endometriosis lesions: Comparison with endometrial tissue, Am. J. Obstet. Gynecol, 141, pp. 562-566, (1981)